A phase III study of primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0 transitional cell carcinoma (TCC) of the bladder

Completed

• Conditions: Bladder cancer; Cancer; Transitional cell carcinoma (TCC) of the bladder

• Registration Number: ISRCTN82694463
• Lead Sponsor: Medical Research Council (MRC) (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2001-03-13
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 975

Inclusion Criteria

1. Histologically proven TCC of the bladder with biopsy-proven muscle invasion
2. Tumours considered curable (less than or equal to 7 cm)
3. GFK =50 ml/min (Cockcroft)
4. White blood count (WBC) >3.5 x 10^9/L and platelet count >100 x 10^9/

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified